Skip Navigation LinksHome > July 2012 - Volume 34 - Issue 5 > Quantitative RT-PCR Analysis of the MOZ-CBP Fusion Transcrip...
Journal of Pediatric Hematology/Oncology:
doi: 10.1097/MPH.0b013e318238818f
Clinical and Laboratory Observations

Quantitative RT-PCR Analysis of the MOZ-CBP Fusion Transcript in Therapy-related Acute Myeloid Leukemia With t(8;16)(p11;p13)

Fujiki, Atsushi MD; Imamura, Toshihiko MD; Furutani, Akiyo MD; Hatano, Waka MD; Asai, Daisuke MD; Hirashima, Yoshifumi MD; Miyachi, Mitsuru MD; Tamura, Shinichi MD; Tsuchiya, Kunihiko MD; Iehara, Tomoko MD; Ishida, Hiroyuki MD; Yoshihara, Takao MD; Hosoi, Hajime MD

Collapse Box


We developed a real time reverse transcriptase polymerase chain reaction (RT-PCR) assay system for detecting the MOZ-CBP fusion transcript and used it to monitor minimal residual disease (MRD) status in a patient with therapy related acute myeloid leukemia (t-AML) harboring t(8;16)(p11;p13). Expression of the MOZ-CBP fusion transcript was determined by RT-PCR analysis of the patient’s bone marrow at the time of diagnosis. Thereafter, real time RT-PCR was used to evaluate MRD levels throughout the entire course of treatment. The sensitivity of quantitative RT-PCR for the MOZ-CBP fusion transcript was 10−5. Below this level, MRD was classified as negative. Real time RT-PCR of the bone marrow after induction therapy showed the reduction of MOZ-CBP transcript to approximately 10−3 level when compared to the diagnostic sample. MRD was classified as negative (<10−5 compared with that in the bone marrow at diagnosis) after 5 courses of chemotherapy, a level that was maintained post-allo-hematopoietic stem cell transplantation. Real time RT-PCR of the MOZ-CBP transcript is a useful tool for assessing MRD status for a patient with therapy related acute myeloid leukemia who was initially predicted to have a poor prognosis.

Copyright © 2012 Wolters Kluwer Health, Inc. All rights reserved.


Article Tools


Article Level Metrics

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.

Connect With Us


For additional oncology content, visit LWW Oncology Journals on Facebook.